SRAX, Inc.
SRAX
$0.24
-$0.06-20.00%
| Weiss Ratings | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.10 | |||
| Price History | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -25.00% | |||
| 30-Day Total Return | -14.29% | |||
| 60-Day Total Return | -33.33% | |||
| 90-Day Total Return | 242.86% | |||
| Year to Date Total Return | 4.35% | |||
| 1-Year Total Return | 478.31% | |||
| 2-Year Total Return | -52.00% | |||
| 3-Year Total Return | -95.03% | |||
| 5-Year Total Return | -88.09% | |||
| 52-Week High % Change | -33.33% | |||
| 52-Week Low % Change | 149,900.00% | |||
| Price | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.45 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 12, 2024 | |||
| 52-Week High Price (Date) | May 28, 2024 | |||
| Valuation | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.75M | |||
| Enterprise Value | 1.72M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.28 | |||
| Earnings Per Share Growth | 19.61% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.44 | |||
| Price/Book (Q) | -1.63 | |||
| Enterprise Value/Revenue (TTM) | 0.07 | |||
| Price | $0.24 | |||
| Enterprise Value/EBITDA (TTM) | 0.32 | |||
| Enterprise Value/EBIT | 0.33 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 35.61M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -1.11% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (323) 694-9800 | |||
| Address | 2629 Townsgate Road Westlake Village, CA 91361 | |||
| Website | www.srax.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 21.39% | |||
| Profit Margin | -134.32% | |||
| Management Effectiveness | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 9.12% | |||
| Return on Equity | -- | |||
| Income Statement | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 24.37M | |||
| Total Revenue (TTM) | 24.37M | |||
| Revenue Per Share | $0.69 | |||
| Gross Profit (TTM) | 21.68M | |||
| EBITDA (TTM) | 5.44M | |||
| EBIT (TTM) | 5.21M | |||
| Net Income (TTM) | -32.74M | |||
| Net Income Avl. to Common (TTM) | -33.11M | |||
| Total Revenue Growth (Q YOY) | -46.47% | |||
| Earnings Growth (Q YOY) | -29.53% | |||
| EPS Diluted (TTM) | -1.28 | |||
| EPS Diluted Growth (Q YOY) | -46.15% | |||
| Balance Sheet | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 8.13M | |||
| Cash Per Share (Q) | $0.23 | |||
| Total Current Assets (Q) | 8.56M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -5.30M | |||
| Current Ratio (Q) | 0.603 | |||
| Book Value Per Share (Q) | -$0.18 | |||
| Total Assets (Q) | 14.51M | |||
| Total Current Liabilities (Q) | 14.19M | |||
| Total Debt (Q) | 6.90M | |||
| Total Liabilities (Q) | 19.81M | |||
| Total Common Equity (Q) | -5.30M | |||
| Cash Flow | SRAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 10.85M | |||
| Cash from Financing (TTM) | 1.68M | |||
| Net Change in Cash (TTM) | 414.00K | |||
| Levered Free Cash Flow (TTM) | -6.89M | |||
| Cash from Operations (TTM) | -12.11M | |||
